Astrid Marilyn Manuel

Ms. Astrid Marilyn Manuel

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2000 in Genomics
Verified
Journal Article
Closed access
AMAstrid Marilyn Manuel
Astrid Marilyn Manuel
DBD. Beaupain
D. Beaupain
PRP.H. Romeo
P.H. Romeo
NRN. Raich
N. Raich

28 May 2022 in Human Molecular Genetics
Verified
Journal Article
Closed access
PDF file
ALAndi Liu
Andi Liu
AMAstrid Marilyn Manuel
Astrid Marilyn Manuel
YDYulin Dai
Yulin Dai
BFBrisa S Fernandes
Brisa S Fernandes
NENitesh Enduru
Nitesh Enduru
ZZZhongming Zhao
Zhongming Zhao
Genome-wide association studies (GWAS) have identified more than 75 genetic variants associated with Alzheimer’s disease (ad). However, how these variants function and impact protein expression in brain regions remain elusive. Large-scale proteomic datasets of ad postmortem brain tissues have become available recently. In this study, we used these datasets to investigate brain region-specific molecular pathways underlying ad pathogenesis and explore their potential drug targets. We applied our new network-based tool, Edge-Weighted Dense Module Search of GWAS (EW_dmGWAS), to integrate ad GWAS statistics of 472 868 individuals with proteomic profiles from two brain regions from two large-scale ad cohorts [parahippocampal gyrus (PHG), sample size n = 190; dorsolateral prefrontal cortex (DLPFC), n = 192]. The resulting network modules were evaluated using a scale-free network index, followed by a cross-region consistency evaluation. Our EW_dmGWAS analyses prioritized 52 top module genes (TMGs) specific in PHG and 58 TMGs in DLPFC, of which four genes (CLU, PICALM, PRRC2A and NDUFS3) overlapped. Those four genes were significantly associated with ad (GWAS gene-level false discovery rate < 0.05). To explore the impact of these genetic components on TMGs, we further examined their differentially co-expressed genes at the proteomic level and compared them with investigational drug targets. We pinpointed three potential drug target genes, APP, SNCA and VCAM1, specifically in PHG. Gene set enrichment analyses of TMGs in PHG and DLPFC revealed region-specific biological processes, tissue-cell type signatures and enriched drug signatures, suggesting potential region-specific drug repurposing targets for ad.

17 July 2021 in Molecular and Cellular Neuroscience
Verified
Journal Article
Closed access
AMAstrid Marilyn Manuel
Astrid Marilyn Manuel
YDYulin Dai
Yulin Dai
LFLeorah A. Freeman
Leorah A. Freeman
PJPeilin Jia
Peilin Jia
ZZZhongming Zhao
Zhongming Zhao

3 April 2020 in BMC Medical Genomics
Verified
Journal Article
Open access
PDF file
AMAstrid Marilyn Manuel
Astrid Marilyn Manuel
YDYulin Dai
Yulin Dai
LFLeorah A. Freeman
Leorah A. Freeman
PJPeilin Jia
Peilin Jia
ZZZhongming Zhao
Zhongming Zhao
Background: Multiple sclerosis (MS) is a complex disease in which the immune system attacks the central nervous system. The molecular mechanisms contributing to the etiology of MS remain poorly understood. Genome-wide association studies (GWAS) of MS have identified a small number of genetic loci significant at the genome level, but they are mainly non-coding variants. Network-assisted analysis may help better interpret the functional roles of the variants with association signals and potential translational medicine application. The Dense Module Searching of GWAS tool (dmGWAS version 2.4) developed in our team is applied to 2 MS GWAS datasets (GeneMSA and IMSGC GWAS) using the human protein interactome as the reference network. A dual evaluation strategy is used to generate results with reproducibility.Results: Approximately 7500 significant network modules were identified for each independent GWAS dataset, and 20 significant modules were identified from the dual evaluation. The top modules includedGRB2, HDAC1,JAK2,MAPK1,andSTAT3as central genes. Top module genes were enriched with functional terms such as “regulation of glial cell differentiation” (adjustedp-value = 2.58 × 10− 3), “T-cell costimulation” (adjustedp-value = 2.11 × 10− 6) and “virus receptor activity” (adjustedp-value = 1.67 × 10− 3). Interestingly, top gene networks included several MS FDA approved drug target genesHDAC1,IL2RA,KEAP1, andRELA,Conclusions: Our dmGWAS network analyses highlighted several genes (GRB2, HDAC1, IL2RA, JAK2, KEAP1, MAPK1, RELAandSTAT3) in top modules that are promising to interpret GWAS signals and link to MS drug targets. The genes enriched with glial cell differentiation are important for understanding neurodegenerative processes in MS and for remyelination therapy investigation. Importantly, our identified genetic signals enriched in T cell costimulation and viral receptor activity supported the viral infection onset hypothesis for MS.

25 October 2022 in Human Molecular Genetics
Verified
Journal Article
Closed access
PDF file
AMAstrid Marilyn Manuel
Astrid Marilyn Manuel
YDYulin Dai
Yulin Dai
PJPeilin Jia
Peilin Jia
LFLeorah A Freeman
Leorah A Freeman
ZZZhongming Zhao
Zhongming Zhao
Multiple sclerosis (MS) is a complex dysimmune disorder of the central nervous system. Genome-wide association studies (GWAS) have identified 233 genetic variations associated with MS at the genome-wide significant level. Epigenetic studies have pinpointed differentially methylated CpG sites in MS patients. However, the interplay between genetic risk factors and epigenetic regulation remains elusive. Here, we employed a network model to integrate GWAS summary statistics of 14 802 MS cases and 26 703 controls with DNA methylation profiles from 140 MS cases and 139 controls and the human interactome. We identified differentially methylated genes by aggregating additive effects of differentially methylated CpG sites within promoter regions. We reconstructed a gene regulatory network (GRN) using literature-curated transcription factor knowledge. Colocalization of the MS GWAS and methylation quantitative trait loci (mQTL) was performed to assess the GRN. The resultant MS-associated GRN highlighted several single nucleotide polymorphisms with GWAS-mQTL colocalization: rs6032663, rs6065926 and rs2024568 of CD40 locus, rs9913597 of STAT3 locus, and rs887864 and rs741175 of CIITA locus. Moreover, synergistic mQTL and expression QTL signals were identified in CD40, suggesting gene expression alteration was likely induced by epigenetic changes. Web-based Cell-type Specific Enrichment Analysis of Genes (WebCSEA) indicated that the GRN was enriched in T follicular helper cells (P-value = 0.0016). Drug target enrichment analysis of annotations from the Therapeutic Target Database revealed the GRN was also enriched with drug target genes (P-value = 3.89 × 10−4), revealing repurposable candidates for MS treatment. These candidates included vorinostat (HDAC1 inhibitor) and sivelestat (ELANE inhibitor), which warrant further investigation.

19 December 2025 in Science Advances
Verified
Journal Article
Open access
ALAndi Liu
Andi Liu
CCCitu Citu
Citu Citu
NENitesh Enduru
Nitesh Enduru
XCXian Chen
Xian Chen
CTChia-Hao Tung
Chia-Hao Tung
ZZZhongming Zhao
Zhongming Zhao
Sporadic early-onset Alzheimer’s disease (sEOAD) represents a substantial but less-studied subtype of Alzheimer’s disease (AD). Here, we generated a single-nucleus multiome atlas derived from the postmortem prefrontal cortex, entorhinal cortex, and hippocampus of nine individuals with or without sEOAD. Comprehensive analyses were conducted to delineate cell type–specific transcriptomic changes and linked candidate cis - regulatory elements (cCREs) across brain regions. We prioritized eight conservative transcription factors in glial cells in multiple brain regions, including RFX4 in astrocytes and IKZF1 in microglia, which are implicated in regulating sEOAD-associated genes. Moreover, we identified the top 25 altered intercellular signaling between glial cells and neurons, highlighting their regulatory potential on gene expression in receiver cells. We reported 33 cCREs linked to sEOAD-associated genes overlapped with late-onset AD risk loci, and found that, in addition, sEOAD cCREs are enriched for neuropsychiatric disorder risk variants. This atlas helps dissect transcriptional and chromatin dynamics in sEOAD, providing a key resource for AD research.